Insights from our team
We understand how important it is to work somebody who ‘knows-their-stuff’ when it comes to your talent strategy. At Fraser Dove, our team are passionate about supporting the life sciences. We actively encourage our people to stay informed of the latest industry trends and translate this into digestible content for you to hopefully learn something new from a different perspective.
How COVID-19 Has Changed People’s Perception of Pharma: The Good, T...
By Thomas Dove “I’ve got Moderna.” I said to a friend. “Oh, that one’s good, isn’t it? I’ve got AstraZeneca.” Another friend piped up in the conversation. “That’s the dodgy…Read more
Debunking the Stigma Around Medicinal Cannabis: Pharma’s Latest Gam...
By Alice Wearn The European medicinal cannabis market is growing exponentially and is expected to reach €3.2 billion by 2025. We’re seeing more and more countries legalise and utilise medicinal…Read more
Culture Change and Overcoming Resistance in Quality
By Peter Vedde Quite often, Quality is the last thing on a life science company’s agenda. For reasons touched on in my colleague’s article on driving Quality up the agenda,…Read more
Has COVID-19 Accelerated Industry 4.0 in the Life Sciences?
By Richard Dane The COVID-19 pandemic has taken the world by storm, but none more so than in the world of manufacturing. Manufacturing is experiencing a period of rapid transformation…Read more
Supply Chain vs COVID-19 – What Have Been the Effects of the Pandem...
By Liam Wallis 2020 was an unprecedented year for Supply Chains. A spotlight was shone in its direction like never before. Supply Chains were asked to solve problems on a…Read more
Women in Life Sciences: Diversifying the Workforce
By Alice Wearn The life science industry is under pressure like never before to diversify their workforce, particularly for senior leadership positions. This comes following the number of reports revealing…Read more
Driving Quality Up The Agenda: What Needs To Be Done?
By Jason Cachia While I’m not a technical expert within Quality, I speak to executives every day who are. Common topics keep coming up in our discussions that I feel…Read more
Is It Time To Bring Drug Manufacturing Back To The US?
By Brett Lofthouse With the coronavirus pandemic exposing cracks in the global pharmaceutical industry’s weak supply chain, large drug companies are waking up to the facts; something needs to change…Read more
Are Local CDMOs Going To Save Pharma?
By Harry Simpson The coronavirus pandemic has exposed something in the pharmaceutical industry that has been evident for a long time – a weak and unsustainable global supply chain. While…Read more